Nicole R. Hadas - Net Worth and Insider Trading

Nicole R. Hadas Net Worth

The estimated net worth of Nicole R. Hadas is at least $1 Million dollars as of 2024-11-05. Nicole R. Hadas is the SVP, Chief Legal Officer of Akebia Therapeutics Inc and owns about 651,243 shares of Akebia Therapeutics Inc (AKBA) stock worth over $1 Million. Details can be seen in Nicole R. Hadas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicole R. Hadas has not made any transactions after 2024-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nicole R. Hadas

To

Nicole R. Hadas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicole R. Hadas owns 1 companies in total, including Akebia Therapeutics Inc (AKBA) .

Click here to see the complete history of Nicole R. Hadas’s form 4 insider trades.

Insider Ownership Summary of Nicole R. Hadas

Ticker Comapny Transaction Date Type of Owner
AKBA Akebia Therapeutics Inc 2024-05-13 SVP & General Counsel & Sec.

Nicole R. Hadas Latest Holdings Summary

Nicole R. Hadas currently owns a total of 1 stock. Nicole R. Hadas owns 651,243 shares of Akebia Therapeutics Inc (AKBA) as of May 13, 2024, with a value of $1 Million.

Latest Holdings of Nicole R. Hadas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKBA Akebia Therapeutics Inc 2024-05-13 651,243 1.85 1,204,800

Holding Weightings of Nicole R. Hadas


Nicole R. Hadas Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicole R. Hadas has made a total of 8 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 12,016 shares on May 13, 2024, which brought Nicole R. Hadas around $15,140.

Insider Trading History of Nicole R. Hadas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicole R. Hadas Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nicole R. Hadas Ownership Network

Ownership Network List of Nicole R. Hadas

No Data

Ownership Network Relation of Nicole R. Hadas

Insider Network Chart

Nicole R. Hadas Owned Company Details

What does Akebia Therapeutics Inc do?

Who are the key executives at Akebia Therapeutics Inc?

Nicole R. Hadas is the SVP & General Counsel & Sec. of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & Chief Medical Officer Steven Keith Burke , and director & CEO & President John P. Butler .

Akebia Therapeutics Inc (AKBA) Insider Trades Summary

Over the past 18 months, Nicole R. Hadas made 4 insider transaction in Akebia Therapeutics Inc (AKBA) with a net sale of 88,587. Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 149,723 shares made by Michel Dahan , a net sale of 106,103 shares made by Steven Keith Burke , and a net sale of 84,303 shares made by John P. Butler .

In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 492,283 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,283 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akebia Therapeutics Inc Insider Transactions

No Available Data

Nicole R. Hadas Mailing Address

Above is the net worth, insider trading, and ownership report for Nicole R. Hadas. You might contact Nicole R. Hadas via mailing address: 20 Pilgram Drive, Winchester Ma 01890.